FDA Appears to Back HIV Drug

May 8, 2012, 9:09 am by Wall Street Journal

The FDA appeared to support the use of a Gilead HIV drug in healthy people to help prevent them from contracting the virus that causes AIDS.

Read the full article

More from Wall Street Journal

New Tracking of a Patient's Radiation Exposure
Wall Street Journal : May 21, 2013, 12:01 pm
Some hospital groups are measuring and reporting patients' cumulative medical radiation exposure from tests and scans. How this move may shape treatment and care decisions for patients and their doctors.

Can You Catch Up on Lost Sleep?
Wall Street Journal : May 20, 2013, 9:21 am
Will sleeping more on the weekend make up for lost sno

Actavis to Buy Warner Chilcott
Wall Street Journal : May 20, 2013, 9:10 am
Actavis agreed to acquire Warner Chilcott in a stock swap that values the maker of prescription health-care and dermatology products for women at roughly $5 billion.

When Social Skills Are a Warning
Wall Street Journal : May 20, 2013, 7:47 am
Behavior changes can serve as an early signal of mental-health issues, recent research indicates.Recognizing social changes that previously might have been shrugged off could allow for earlier treatment, doctors say.

FDA Staff: Merck Sleep Drug Effective but Some Dosage Concerns
Wall Street Journal : May 20, 2013, 5:09 am
FDA staff said a proposed sleep drug from Merck was effective, but questioned the safety of the product's higher doses. Merck is seeking FDA approval of a drug called suvorexant to treat